Related Experiment Video
Updated: May 26, 2026
05:41
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Fecal microbiota transplantation and emerging applications
Thomas J Borody1, Alexander Khoruts
1Centre for Digestive Diseases, Level 1, 229 Great North Road, Sydney, NSW 2046, Australia. thomas.borody@ cdd.com.au
Nature Reviews. Gastroenterology & Hepatology
|December 21, 2011
Summary
Fecal microbiota transplantation (FMT) is a highly effective treatment for Clostridium difficile infection. Emerging research suggests FMT may also treat other conditions linked to gut microbiota dysfunction.
Area of Science:
- Microbiology
- Gastroenterology
- Immunology
Background:
- Fecal microbiota transplantation (FMT) has a long history, with recent resurgence due to Clostridium difficile infection (CDI) epidemics.
- FMT demonstrates high efficacy in eradicating CDI and its symptoms, leading to increased clinical use.
- Growing research recognizes the gut microbiota as a crucial 'microbial organ' influencing immunity and metabolism.
Purpose of the Study:
- To explore the expanding applications of FMT beyond CDI.
- To highlight the potential of FMT in treating idiopathic conditions linked to microbiota dysfunction.
- To underscore the need for rigorous clinical trials in the emerging field of microbiota-related disorders.
Main Methods:
- Review of existing literature on FMT efficacy and applications.
- Analysis of emerging research on the gut microbiota's role in health and disease.
- Identification of potential new therapeutic targets for FMT.
Main Results:
- FMT is highly effective for Clostridium difficile infection (CDI).
- Reports indicate FMT's potential utility in various idiopathic conditions.
- The gut microbiota's role in immunity and metabolism is increasingly understood.
Conclusions:
- FMT shows promise for treating a range of disorders beyond CDI, including IBD, IBS, metabolic syndrome, and autoimmune/allergic diseases.
- The field of microbiota-related disorders is rapidly evolving.
- Well-designed randomized trials are essential to validate FMT's efficacy for these new indications.
Related Concept Videos
01:22Introduction to the Human Microbiota
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
01:50What is Monogastric Digestion?
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:30Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
01:18Functions of the Gut Microbiota
The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
01:27Microbiota of the Large Intestine
The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...